NASDAQ : NTHI
NeOnc Technologies Holdings, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 3.26 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 81.03M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 81.03M |
| Enterprise Value | 79.39M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 24.86M |
| Shares Outstanding | 24.86M |
| Shares Change (YoY) | +20.49% |
| Shares Change (QoQ) | +5.88% |
| Owned by Insiders (%) | 56.11% |
| Owned by Institutions (%) | 6.46% |
| Float | 8.10M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,026.34 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1,985.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.18 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.33 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -634.99% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 228.50% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $7,998 |
| Profits Per Employee | -$9.44M |
| Employee Count | 5 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -66.30% |
| 50-Day Moving Average | 3.48 |
| 200-Day Moving Average | 5.47 |
| Relative Strength Index (RSI) | 54.72 |
| Average Volume (20 Days) | 144,317 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 876,682 |
| Short Previous Month | 757,739 |
| Short % of Shares Out | 3.53% |
| Short % of Float | 10.82% |
| Short Ratio (days to cover) | 4.73 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 39,990 |
| Gross Profit | 39,990 |
| Operating Income | -41.76M |
| Pretax Income | -47.20M |
| Net Income | -47.20M |
| EBITDA | n/a |
| EBIT | -41.76M |
| Loss Per Share | -$2.14 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.97M |
| Total Debt | 328,217 |
| Net Cash | 1.65M |
| Net Cash Per Share | $0.07 |
| Equity (Book Value) | -18.53M |
| Book Value Per Share | -0.87 |
| Working Capital | -19.32M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -21.16M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 57,304 |
| Net Borrowing | -2.67M |
| Free Cash Flow | -21.16M |
| FCF Per Share | -$0.85 |
Margins
| Measure | Value |
|---|
| Gross Margin | 100.00% |
| Operating Margin | -104,418.90% |
| Pretax Margin | -118,029.51% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -20.49% |
| Shareholder Yield | -20.49% |
| Earnings Yield | -65.53% |
| FCF Yield | -26.11% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $17.00 |
| Price Target Difference | 421.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -63.24 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |